0      0

FRI03 - Care Coordination in Emerging Therapies

‐ May 5, 2023 3:30pm

2.0 CE credits/hours

Join this session to discuss the challenges of and strategies for coordinating care for patients receiving therapies such as bispecific antibodies or chimeric antigen receptor (CAR) T-cell therapy in academic and community settings.

Learning Objectives:

  • Identify challenges associated with transitioning care from inpatient to outpatient in the setting of immunotherapy agents with risk of cytokine release syndrome (CRS) or immune effector cell associated neurotoxicity (ICANS)
  • Discuss inpatient and outpatient CRS management of bispecific antibody therapies and indications for readmission
  • Demonstrate confidence in the management of bispecific antibody therapies in the community setting


You must be logged in and own this session in order to post comments.